Teladoc Health, Inc.

Teladoc Health, Inc. announced the appointment of David Packles as the new Head of Product for its BetterHelp subsidiary, effective July 1, 2026. In connection with his new role, Mr. Packles received an inducement award of 50,000 restricted stock units of Teladoc Health's common stock. The award, approved by the Compensation Committee, vests over approximately three years, with one-third vesting on the first anniversary and the remainder quarterly over the subsequent two years.

Teladoc Health, Inc. reported Q1 2026 financial results with revenue down 2% year-over-year to $613.8 million. The company's net loss improved by 31% to $63.8 million, or $0.36 per share, while adjusted EBITDA remained essentially flat at $58.2 million. Integrated Care segment revenue grew 2%, offsetting a 9% decline in the BetterHelp segment. Teladoc Health reaffirmed the midpoint of its full-year financial outlook for 2026.

Teladoc Health, Inc. announced it will release its first-quarter 2026 financial results on Wednesday, April 29, 2026, after the market closes. The company will host a conference call at 5:00 p.m. ET on the same day to discuss the results. Investors can access the call via dial-in or a live audio webcast, with a replay available for approximately 90 days.